Knowledge IVD Principles & Technologies What primary detection labels are used in immunoassays, and how do they guide reader selection?
Author avatar

Tech Team · CamelBio

Updated 1 month ago

What primary detection labels are used in immunoassays, and how do they guide reader selection?


The choice of detection label is the single most critical decision shaping your microplate reader requirements.

The primary detection labels used in immunoassays are enzymes (e.g., HRP, alkaline phosphatase), fluorochromes (e.g., FITC), chemiluminescent compounds (e.g., acridinium esters), and radioisotopes (e.g., Iodine-125). Each label generates a fundamentally different physical signal—color, fluorescence, light, or radiation—which rigidly dictates the required microplate reader. Enzyme labels demand a spectrophotometer, fluorometer, or luminometer depending on the substrate used. Fluorochromes require a fluorometer. Chemiluminescent labels need a luminometer. Radioisotopes rely on gamma or scintillation counters, which typically fall outside modern optical microplate reader systems.

The signal output of your label is non-negotiable. An absorbance-based enzyme assay cannot be read on a basic luminometer. Your label choice precisely determines whether you need a spectrophotometer, fluorometer, or luminometer—or a multi-mode microplate reader that integrates these capabilities.

The Four Primary Detection Labels and Their Reader Requirements

Each label family converts biological recognition into a measurable output through a distinct physical process. Understanding this process is the foundation of instrument selection.

Enzymatic Labels: Substrate-Dependent Reader Selection

Enzyme labels like horseradish peroxidase (HRP) or alkaline phosphatase (AP) are the most versatile workhorses.

They do not emit a signal directly. Instead, they react with a specific substrate to produce a detectable product. The reader required depends entirely on the chosen substrate.

Chromogenic substrates (e.g., TMB, pNPP) generate a colored, soluble product. This requires an absorbance microplate reader (spectrophotometer) to measure optical density at a specific wavelength.

Fluorogenic substrates yield a fluorescent molecule. This demands a fluorometer with the correct excitation and emission filters.

Chemiluminescent substrates trigger a direct light emission. This needs a highly sensitive luminometer.

Thus, a single enzyme label can drive very different reader purchases based on your substrate strategy.

Fluorochrome Labels: Direct Fluorescence Measurement

Fluorochromes like fluorescein isothiocyanate (FITC) are directly conjugated to the detection antibody.

They absorb light at one wavelength and instantly re-emit it at a longer wavelength. Detection requires a fluorometer or fluorescence-capable microplate reader.

The instrument must provide a precise excitation source and capture the emitted light through a filter or monochromator, making wavelength matching a critical hardware consideration.

Chemiluminescent Compounds: Light Without Excitation

Labels like acridinium esters generate light through a chemical reaction, requiring no external light source at all.

Detection is performed by a luminometer, which is essentially a highly sensitive photon counter. Microplate luminometers are optimized for ultra-low noise, high-gain light measurement.

This label-reader pairing provides the highest potential sensitivity but requires instruments capable of handling fast, transient "flash" kinetics.

Radioisotopes: The Non-Optical Detection

Radioactive labels (e.g., I-125, tritium) emit gamma or beta radiation.

They are not compatible with any optical microplate reader. They require gamma counters or liquid scintillation counters. Due to safety, regulatory, and waste-disposal hurdles, they are rarely used in high-throughput microplate workflows today.

Direct vs. Indirect Assays: Same Label, Same Reader Logic

The assay architecture does not change the reader dependence.

Whether the label is attached directly to the primary antibody or to a secondary antibody (as in an indirect assay), the physical signal generated is identical. An indirect assay using an HRP-conjugated secondary antibody and a TMB substrate will always end in an absorbance-based spectrophotometer readout.

The indirect method amplifies the signal, but it doesn't alter the fundamental detection mechanism. Reader selection is label-driven, not format-driven.

Understanding the Trade-offs in Label and Reader Selection

Each combination presents a distinct balance of sensitivity, cost, and workflow complexity that directly influences your instrument investment.

Sensitivity and Dynamic Range Constraints

Enzymatic/Colorimetric systems are robust and run on affordable spectrophotometers. The trade-off is lower sensitivity and a narrower dynamic range compared to other methods. The extra substrate incubation step adds time and manual variability.

Fluorescence offers higher sensitivity and the power of multiplexing. The downside is that fluorophores can photobleach, and autofluorescence from microplates or reagents can erode signal-to-noise ratios. Readers are more expensive.

Chemiluminescence delivers the highest sensitivity for low-abundance biomarkers. The trade-off is timing: flash reactions require luminometers with onboard injectors for precise reagent addition, increasing instrument cost and complexity.

Infrastructure and Workflow Lock-In

Selecting a single-mode reader—like a dedicated spectrophotometer—locks your lab into that label type, limiting future assay flexibility. A multi-mode reader that handles absorbance, fluorescence, and luminescence avoids this lock-in but at a much higher upfront capital cost.

Radioisotope-based detection, while exquisitely sensitive, demands separate, specialized counters and is a significant regulatory burden.

Making the Right Choice for Your Goal

Align your label and reader selection with your core analytical need and available resources to build a robust, efficient workflow.

  • If your primary focus is maximizing sensitivity for ultra-low abundance targets: Choose a chemiluminescent label and a high-quality luminometer with reagent injectors to handle flash kinetics reliably.
  • If your primary focus is routine, cost-effective assays with well-established endpoints: An enzymatic label with a chromogenic substrate paired with a simple absorbance reader is the proven, economical standard.
  • If your primary focus is multiplexing or high-content analysis: Opt for fluorochromes and a fluorescence reader or flow cytometer, ensuring you have the correct filter sets for your dyes.
  • If your primary focus is future-proofing your lab for multiple assay types: Invest in a multi-mode microplate reader that covers absorbance, fluorescence, and luminescence, granting total label flexibility.

Let the physical signal of your chosen label be the decisive factor that guides your instrument acquisition, ensuring a perfect match between your biology and your detection hardware.

Summary Table:

Detection Label Signal Output Required Microplate Reader Key Trade-offs & Benefits
Enzyme (Chromogenic) Optical Density / Color Absorbance Spectrophotometer Cost-effective and robust; lower sensitivity
Fluorochrome / Fluorogenic Fluorescent Light Fluorometer High sensitivity and multiplexing capability; prone to background autofluorescence
Chemiluminescent Compound Direct Light Emission Luminometer (with injectors) Highest sensitivity for low-abundance targets; fast kinetics require precise timing
Radioisotope Gamma / Beta Radiation Gamma or Scintillation Counter Non-optical detection; requires strict safety and regulatory compliance

Accelerate Your Immunoassay Development with CamelBio

Choosing the right detection labels and substrate chemistry is critical to optimizing assay sensitivity and ensuring seamless hardware compatibility.

At CamelBio, we empower diagnostic manufacturers, clinical labs, and research institutes with one-stop access to high-quality IVD raw materials, specialized technical services, and end-to-end consulting—guiding your project smoothly every step of the way from concept to clinic.

Ready to optimize your assay performance or source superior reagents? Contact CamelBio today to speak with our experts!


Leave Your Message